Molecular therapeutic strategies targeting Duchenne muscular dystrophy.

Abstract excerpt

Since the discovery of the gene for Duchenne muscular dystrophy more than 20 years ago, scientists have worked to apply molecular principles for restoration of the dystrophin protein and correction of the underlying physiologic defect that predisposes muscle fibers to injury. Recent studies provide realistic hope that molecular therapies may help patients who have this disorder. At present, only corticosteroids...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child
• Share to Genetic Predisposition to Disease
• Share to Genetic Therapy